Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Computationally designed proteins mimic antibody immune evasion in viral evolution

Title: Computationally designed proteins mimic antibody immune evasion in viral evolution
Authors: Youssef, Noor; Gurev, Sarah; Ghantous, Fadi; Brock, Kelly P; Jaimes, Javier A; Thadani, Nicole N; Dauphin, Ann; Sherman, Amy C; Yurkovetskiy, Leonid; Soto, Daria; Estanboulieh, Ralph; Kotzen, Ben; Notin, Pascal; Kollasch, Aaron W; Cohen, Alexander A; Dross, Sandra E; Erasmus, Jesse; Fuller, Deborah H; Bjorkman, Pamela J; Lemieux, Jacob E; Luban, Jeremy; Seaman, Michael S; Marks, Debora S
Contributors: Program in Molecular Medicine
Source: Immunity ; United States
Publication Year: 2025
Collection: University of Massachusetts, Medical School: eScholarship@UMMS
Subject Terms: antibody escape; generative protein models; immune landscape; machine learning; protein design; vaccine evaluation; viral evolution
Description: Recurrent waves of viral infection necessitate vaccines and therapeutics that remain effective against emerging viruses. Our ability to evaluate interventions is currently limited to assessments against past or circulating variants, which likely differ in their immune escape potential compared with future variants. To address this, we developed EVE-Vax, a computational method for designing antigens that foreshadow immune escape observed in future viral variants. We designed 83 SARS-CoV-2 spike proteins that transduced ACE2-positive cells and displayed neutralization resistance comparable to variants that emerged up to 12 months later in the COVID-19 pandemic. Designed spikes foretold antibody escape from B.1-BA.4/5 bivalent booster sera seen in later variants. The designed constructs also highlighted the increased neutralization breadth elicited by nanoparticle-based, compared with mRNA-based, boosters in non-human primates. Our approach offers targeted panels of synthetic proteins that map the immune landscape for early vaccine and therapeutic evaluation against future viral strains. ; No embargo
Document Type: article in journal/newspaper
File Description: application/pdf
Language: English
Relation: Immunity; https://doi.org/10.1016/j.immuni.2025.04.015; https://hdl.handle.net/20.500.14038/54417
DOI: 10.1016/j.immuni.2025.04.015
Availability: https://doi.org/10.1016/j.immuni.2025.04.015; https://hdl.handle.net/20.500.14038/54417
Rights: © 2025 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). ; http://creativecommons.org/licenses/by/4.0/
Accession Number: edsbas.5131D266
Database: BASE